Seung Yoon Lee
Rheumatology · Murray, UTNPI 1649567835
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $15,150 of the $22,307 with a category attached, or 67.9%. Amgen accounts for 78.1% of it on its own, with 18 other manufacturers making up the rest. 2025 is the largest year on record at $15,567, more than ten times the $613 reported in 2019. Among rheumatology clinicians in UT with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 292 payments — averaging $76.40 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$17K
- AbbVie$1K
- Johnson & Johnson$915
- UCB, Inc.$690
- Novartis$548
- Samsung Bioepis Co., Ltd.$500
- plus $896 from 13 others
What the payments were for
- Speaking & faculty fees$15,15068%
- Travel & lodging$1,4597%
- Food & beverage$5,41324%
- Education$2861%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amgen(2 entities) | 91 | $17,425 |
| AbbVie | 54 | $1,333 |
| Johnson & Johnson | 21 | $915 |
| UCB, Inc. | 18 | $690 |
| Novartis | 27 | $548 |
| Samsung Bioepis Co., Ltd. | 1 | $500 |
| Pfizer | 50 | $345 |
| Lilly USA, LLC | 5 | $116 |
| AstraZeneca | 6 | $112 |
| GSK | 4 | $61 |
| Genentech USA, Inc. | 3 | $56 |
| Fresenius Kabi USA, LLC | 3 | $52 |
| E.r. Squibb & Sons, L.L.C. | 2 | $35 |
| Boehringer Ingelheim | 2 | $30 |
| Sanofi | 1 | $21 |
| Sandoz | 1 | $20 |
| Sobi, Inc | 1 | $17 |
| Ultragenyx Pharmaceutical Inc. | 1 | $17 |
| Mylan Institutional Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$22,307 in reported general payments places this provider in the 90th percentile of 52 rheumatology providers in Utah.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| ActemraTocilizumab | 25 | $81,276 |
| Actemra ActpenTocilizumab | 12 | $59,887 |
| MethotrexateMethotrexate Sodium | 76 | $1,970 |
| Hydroxychloroquine Sulfate | 36 | $1,749 |
| Leflunomide | 23 | $1,186 |
| Methylprednisolone | 16 | $711 |
| Prednisone | 46 | $258 |
| Folic Acid | 15 | $85 |
Paid to pharmacies, not to this prescriber.
Other rheumatology in Murray
- Dany SaadMurray$913
- Danette KoMurray$614
- Sonia GuptaMurray$596
- Brayden YellmanMurray$306
- Don StromquistMurray$0
- Catherine BakewellSalt Lake City$1M
- Jessica WalshSlc$162K
- Shruti SanghviVineyard$63K
- Curry KoeningSalt Lake City$59K
- Carmen GotaSt. George$56K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.